trial · primary record
ASP2020
Stargardt Disease
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 30 |
| Primary completion | 2029-09-30 |
| Primary endpoint | Number of participants with treatment-emergent adverse events (TEAEs) |
| Registry ID | NCT07734064 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:39:03.421Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07734064
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.